Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
Identifieur interne : 003677 ( PubMed/Corpus ); précédent : 003676; suivant : 003678Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
Auteurs : Maarten Boers ; John R. Kirwan ; George Wells ; Dorcas Beaton ; Laure Gossec ; Maria-Antonietta D'Agostino ; Philip G. Conaghan ; Clifton O. Bingham ; Peter Brooks ; Robert Landewé ; Lyn March ; Lee S. Simon ; Jasvinder A. Singh ; Vibeke Strand ; Peter TugwellSource :
- Journal of clinical epidemiology [ 1878-5921 ] ; 2014.
English descriptors
- KwdEn :
- Consensus, Controlled Clinical Trials as Topic (methods), Controlled Clinical Trials as Topic (standards), Health Personnel, Humans, Outcome Assessment (Health Care) (methods), Outcome Assessment (Health Care) (standards), Rheumatic Diseases (therapy), Rheumatology (methods), Rheumatology (standards), Severity of Illness Index, Treatment Outcome.
- MESH :
- methods : Controlled Clinical Trials as Topic, Outcome Assessment (Health Care), Rheumatology.
- standards : Controlled Clinical Trials as Topic, Outcome Assessment (Health Care), Rheumatology.
- therapy : Rheumatic Diseases.
- Consensus, Health Personnel, Humans, Severity of Illness Index, Treatment Outcome.
Abstract
Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process.
DOI: 10.1016/j.jclinepi.2013.11.013
PubMed: 24582946
Links to Exploration step
pubmed:24582946Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.</title><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057, 1007 MB Amsterdam, The Netherlands. Electronic address: eb@vumc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Kirwan, John R" sort="Kirwan, John R" uniqKey="Kirwan J" first="John R" last="Kirwan">John R. Kirwan</name><affiliation><nlm:affiliation>University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Wells, George" sort="Wells, George" uniqKey="Wells G" first="George" last="Wells">George Wells</name><affiliation><nlm:affiliation>Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Beaton, Dorcas" sort="Beaton, Dorcas" uniqKey="Beaton D" first="Dorcas" last="Beaton">Dorcas Beaton</name><affiliation><nlm:affiliation>Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation><nlm:affiliation>Department of Rheumatology, Université Pierre et Marie Curie (UPMC), Paris 6, GRC-UMPC 08 (EEMOIS), and Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria-Antonietta" last="D'Agostino">Maria-Antonietta D'Agostino</name><affiliation><nlm:affiliation>Department of Rheumatology, Université Versailles-Saint Quentin en Yvelines, Ambroise Pare Hospital, Boulogne-Billancourt, France.</nlm:affiliation></affiliation></author><author><name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G" last="Conaghan">Philip G. Conaghan</name><affiliation><nlm:affiliation>NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bingham, Clifton O" sort="Bingham, Clifton O" uniqKey="Bingham C" first="Clifton O" last="Bingham">Clifton O. Bingham</name><affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University, Baltimore, MD 21224, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Brooks, Peter" sort="Brooks, Peter" uniqKey="Brooks P" first="Peter" last="Brooks">Peter Brooks</name><affiliation><nlm:affiliation>School of Population and Global Health, University of Melbourne, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Landewe, Robert" sort="Landewe, Robert" uniqKey="Landewe R" first="Robert" last="Landewé">Robert Landewé</name><affiliation><nlm:affiliation>Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name><affiliation><nlm:affiliation>Institute of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia; Department of Rheumatology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Simon, Lee S" sort="Simon, Lee S" uniqKey="Simon L" first="Lee S" last="Simon">Lee S. Simon</name><affiliation><nlm:affiliation>SDG LLC, Cambridge, MA 02138, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A" last="Singh">Jasvinder A. Singh</name><affiliation><nlm:affiliation>Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Strand, Vibeke" sort="Strand, Vibeke" uniqKey="Strand V" first="Vibeke" last="Strand">Vibeke Strand</name><affiliation><nlm:affiliation>Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94028, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation><nlm:affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24582946</idno><idno type="pmid">24582946</idno><idno type="doi">10.1016/j.jclinepi.2013.11.013</idno><idno type="wicri:Area/PubMed/Corpus">003677</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003677</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.</title><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation><nlm:affiliation>Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057, 1007 MB Amsterdam, The Netherlands. Electronic address: eb@vumc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Kirwan, John R" sort="Kirwan, John R" uniqKey="Kirwan J" first="John R" last="Kirwan">John R. Kirwan</name><affiliation><nlm:affiliation>University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Wells, George" sort="Wells, George" uniqKey="Wells G" first="George" last="Wells">George Wells</name><affiliation><nlm:affiliation>Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Beaton, Dorcas" sort="Beaton, Dorcas" uniqKey="Beaton D" first="Dorcas" last="Beaton">Dorcas Beaton</name><affiliation><nlm:affiliation>Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation><nlm:affiliation>Department of Rheumatology, Université Pierre et Marie Curie (UPMC), Paris 6, GRC-UMPC 08 (EEMOIS), and Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria-Antonietta" last="D'Agostino">Maria-Antonietta D'Agostino</name><affiliation><nlm:affiliation>Department of Rheumatology, Université Versailles-Saint Quentin en Yvelines, Ambroise Pare Hospital, Boulogne-Billancourt, France.</nlm:affiliation></affiliation></author><author><name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G" last="Conaghan">Philip G. Conaghan</name><affiliation><nlm:affiliation>NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bingham, Clifton O" sort="Bingham, Clifton O" uniqKey="Bingham C" first="Clifton O" last="Bingham">Clifton O. Bingham</name><affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University, Baltimore, MD 21224, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Brooks, Peter" sort="Brooks, Peter" uniqKey="Brooks P" first="Peter" last="Brooks">Peter Brooks</name><affiliation><nlm:affiliation>School of Population and Global Health, University of Melbourne, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Landewe, Robert" sort="Landewe, Robert" uniqKey="Landewe R" first="Robert" last="Landewé">Robert Landewé</name><affiliation><nlm:affiliation>Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="March, Lyn" sort="March, Lyn" uniqKey="March L" first="Lyn" last="March">Lyn March</name><affiliation><nlm:affiliation>Institute of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia; Department of Rheumatology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Simon, Lee S" sort="Simon, Lee S" uniqKey="Simon L" first="Lee S" last="Simon">Lee S. Simon</name><affiliation><nlm:affiliation>SDG LLC, Cambridge, MA 02138, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A" last="Singh">Jasvinder A. Singh</name><affiliation><nlm:affiliation>Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Strand, Vibeke" sort="Strand, Vibeke" uniqKey="Strand V" first="Vibeke" last="Strand">Vibeke Strand</name><affiliation><nlm:affiliation>Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94028, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation><nlm:affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of clinical epidemiology</title><idno type="eISSN">1878-5921</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Consensus</term><term>Controlled Clinical Trials as Topic (methods)</term><term>Controlled Clinical Trials as Topic (standards)</term><term>Health Personnel</term><term>Humans</term><term>Outcome Assessment (Health Care) (methods)</term><term>Outcome Assessment (Health Care) (standards)</term><term>Rheumatic Diseases (therapy)</term><term>Rheumatology (methods)</term><term>Rheumatology (standards)</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Controlled Clinical Trials as Topic</term><term>Outcome Assessment (Health Care)</term><term>Rheumatology</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Controlled Clinical Trials as Topic</term><term>Outcome Assessment (Health Care)</term><term>Rheumatology</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Rheumatic Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Consensus</term><term>Health Personnel</term><term>Humans</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24582946</PMID><DateCreated><Year>2014</Year><Month>06</Month><Day>14</Day></DateCreated><DateCompleted><Year>2014</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2014</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5921</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of clinical epidemiology</Title><ISOAbbreviation>J Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.</ArticleTitle><Pagination><MedlinePgn>745-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinepi.2013.11.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0895-4356(13)00488-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be addressed by agreeing on a minimum core set of outcome measures per health condition, containing measures relevant to patients and decision makers. Since 1992, the Outcome Measures in Rheumatology (OMERACT) consensus initiative has successfully developed core sets for many rheumatologic conditions, actively involving patients since 2002. Its expanding scope required an explicit formulation of its underlying conceptual framework and process.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature searches and iterative consensus process (surveys and group meetings) of stakeholders including patients, health professionals, and methodologists within and outside rheumatology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">To comprehensively sample patient-centered and intervention-specific outcomes, a framework emerged that comprises three core "Areas," namely Death, Life Impact, and Pathophysiological Manifestations; and one strongly recommended Resource Use. Through literature review and consensus process, core set development for any specific health condition starts by identifying at least one core "Domain" within each of the Areas to formulate the "Core Domain Set." Next, at least one applicable measurement instrument for each core Domain is identified to formulate a "Core Outcome Measurement Set." Each instrument must prove to be truthful (valid), discriminative, and feasible. In 2012, 96% of the voting participants (n=125) at the OMERACT 11 consensus conference endorsed this model and process.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The OMERACT Filter 2.0 explicitly describes a comprehensive conceptual framework and a recommended process to develop core outcome measurement sets for rheumatology likely to be useful as a template in other areas of health care.</AbstractText><CopyrightInformation>Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boers</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, VU University Medical Center, PK 6Z 165, PO Box 7057, 1007 MB Amsterdam, The Netherlands. Electronic address: eb@vumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaton</LastName><ForeName>Dorcas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gossec</LastName><ForeName>Laure</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Université Pierre et Marie Curie (UPMC), Paris 6, GRC-UMPC 08 (EEMOIS), and Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Agostino</LastName><ForeName>Maria-Antonietta</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Université Versailles-Saint Quentin en Yvelines, Ambroise Pare Hospital, Boulogne-Billancourt, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conaghan</LastName><ForeName>Philip G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bingham</LastName><ForeName>Clifton O</ForeName><Initials>CO</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Division of Rheumatology, Johns Hopkins University, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Population and Global Health, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landewé</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>March</LastName><ForeName>Lyn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia; Department of Rheumatology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Lee S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>SDG LLC, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Jasvinder A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strand</LastName><ForeName>Vibeke</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94028, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tugwell</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Epidemiol</MedlineTA><NlmUniqueID>8801383</NlmUniqueID><ISSNLinking>0895-4356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018849" MajorTopicYN="N">Controlled Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment (Health Care)</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="N">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="N">Rheumatology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biological markers</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Outcome assessment (health care)</Keyword><Keyword MajorTopicYN="N">Reference Standards</Keyword><Keyword MajorTopicYN="N">Research design</Keyword><Keyword MajorTopicYN="N">Rheumatology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24582946</ArticleId><ArticleId IdType="pii">S0895-4356(13)00488-5</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2013.11.013</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003677 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003677 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24582946
|texte= Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24582946" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |